Literature DB >> 18770868

High-affinity Na+/K+-dependent glutamate transporter EAAT4 is expressed throughout the rat fore- and midbrain.

Ann Massie1, Lieselotte Cnops, Ilse Smolders, Robert McCullumsmith, Ron Kooijman, Shin Kwak, Lutgarde Arckens, Yvette Michotte.   

Abstract

Excitatory amino acid transporter 4 (EAAT4), a member of the high-affinity Na+/K+-dependent glutamate transporter family, is highly enriched in Purkinje cells of the cerebellum, although it is not restricted to these cells. The detailed expression of EAAT4 protein in different adult rat fore- and midbrain regions was examined. Despite moderate expression levels compared with the cerebellum, EAAT4 protein was omnipresent throughout the fore- and midbrain. With antibodies raised against the N-terminal mouse EAAT4 sequence, the highest protein expression levels were observed in the substantia nigra pars compacta, ventral tegmental area, paranigral nucleus, habenulo-interpeduncular system, supraoptic nucleus, lateral posterior thalamic nucleus, subiculum, and superficial layers of the superior colliculus. Relatively high levels of EAAT4 protein were also detected in the hippocampal principal cells, in the glutamatergic, gamma-aminobutyric acid (GABA)ergic, dopaminergic and most likely cholinergic cells of all nuclei of the basal ganglia, and in neurons of layers II/III and V of the cerebral cortex. The expression of EAAT4 was confirmed at the mRNA level in some important fore- and midbrain structures by in situ hybridization and reverse transcriptase-polymerase chain reaction (RT-PCR) and estimated to range from 6.7 to 1.6% of the amount in the cerebellum as measured by real-time PCR. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770868     DOI: 10.1002/cne.21823

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  27 in total

1.  Probing for improved potency and in vivo bioavailability of excitatory amino acid transporter subtype 1 inhibitors UCPH-101 and UCPH-102: design, synthesis and pharmacological evaluation of substituted 7-biphenyl analogs.

Authors:  Mette N Erichsen; Jeanette Hansen; Josep A Ruiz; Charles S Demmer; Bjarke Abrahamsen; Jesper F Bastlund; Christoffer Bundgaard; Anders A Jensen; Lennart Bunch
Journal:  Neurochem Res       Date:  2014-02-28       Impact factor: 3.996

Review 2.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

Review 3.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

4.  Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.

Authors:  R C Roberts; J K Roche; R E McCullumsmith
Journal:  Neuroscience       Date:  2014-07-24       Impact factor: 3.590

Review 5.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 6.  Astroglial glutamate transporters coordinate excitatory signaling and brain energetics.

Authors:  Michael B Robinson; Joshua G Jackson
Journal:  Neurochem Int       Date:  2016-03-21       Impact factor: 3.921

Review 7.  Excitatory amino acid transporters: roles in glutamatergic neurotransmission.

Authors:  Christopher B Divito; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2014-01-10       Impact factor: 3.921

8.  RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

Authors:  Jagadeesh Sridhara Rao; Matthew Kellom; Edmund Arthur Reese; Stanley Isaac Rapoport; Hyung-Wook Kim
Journal:  J Affect Disord       Date:  2011-09-16       Impact factor: 4.839

9.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

10.  Update on the neurobiology of schizophrenia: a role for extracellular microdomains.

Authors:  D Shan; S Yates; R C Roberts; R E McCullumsmith
Journal:  Minerva Psichiatr       Date:  2012-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.